Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
The latest announcement is out from Tauns Laboratories, Inc. ( (JP:197A) ).
Tauns Laboratories, Inc. reported a 7.6% increase in net sales for the nine months ending March 31, 2025, with notable rises in operating and net income. The company forecasts continued growth in FY2025, with a slight increase in dividends, reflecting a stable financial position and positive outlook in the healthcare market.
More about Tauns Laboratories, Inc.
Tauns Laboratories, Inc. is a company listed on the Tokyo Stock Exchange, operating in the pharmaceutical and healthcare industry. It focuses on developing and providing diagnostic and therapeutic products, catering to a wide range of healthcare needs.
Average Trading Volume: 612,640
Technical Sentiment Signal: Strong Sell
See more data about 197A stock on TipRanks’ Stock Analysis page.